Microgynon 50

Ethinylestradiol, the active ingredient in Microgynon 50, is a combined oral contraceptive presented as a 50 µg/0.5 mg oral tablet for oral use. Together with levonorgestrel, it works to inhibit ovulation, thicken cervical mucus and alter the endometrium, providing reliable contraception and helping to regulate menstrual cycles in women of reproductive age.

GNH USA supplies Microgynon 50 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets.

Microgynon 50, a combined oral contraceptive, is used to manage reproductive health by influencing hormonal pathways.

- Prevention of pregnancy: provides reliable contraceptive protection for women of childbearing age. - Regulation of menstrual cycles: helps achieve more predictable cycle length and flow.

Microgynon 50 may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: temporary swelling or soreness. - Spotting between periods: light vaginal bleeding.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot traveling to the lungs. - Severe allergic reaction (anaphylaxis): rapid onset of hives, swelling, and breathing difficulty.

Use of Microgynon 50 requires careful consideration of several safety factors.

- Contraindicated in pregnancy: product is Category X and must not be used by pregnant women. - Smoking and age over 35: increased risk of cardiovascular events. - History of thromboembolism: avoid use due to clotting risk. - Liver disease: use with caution as metabolism may be impaired. - Breastfeeding: consult a healthcare provider before use. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Microgynon 50 can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): may reduce contraceptive effectiveness. - Rifampin and other antibiotics: may lower hormone levels. - Protease inhibitor antiretrovirals (e.g., ritonavir): may increase hormone concentrations and side‑effects.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., fluconazole): may raise hormone levels. - St. John’s wort: may decrease contraceptive efficacy. - Thiazide diuretics: may elevate risk of hypertension.